首席执行官Martine Rothblatt出售了2,000股股份,将其股份减少了93.9%,90天内幕销售额为284.9M美元,公司收入低于估计。 CEO Martine Rothblatt sold 2,000 shares, reducing her stake by 93.9%, amid $284.9M in insider sales over 90 days, while company earnings beat estimates.

2025年12月19日,联合治疗公司首席执行官Martine Rothblatt出售了2 000股股份,将其股份减少了93.9%,而90天内内幕销售总额达2.849亿美元,引起了人们的关切。 On December 19, 2025, United Therapeutics CEO Martine Rothblatt sold 2,000 shares, reducing her stake by 93.9%, while insider sales totaling $284.9 million in 90 days raised concerns. 该公司报告,Q3的强劲收入为每股7.16美元,估计被打,收入逐年增加6.8%。 The company reported strong Q3 earnings of $7.16 per share, beating estimates, and saw a 6.8% revenue increase year-over-year. 股价收盘时为517.13美元,接近52周高点,市值为222.27亿美元,分析师一致认为"适度购买". Shares closed at $517.13, near a 52-week high, with a market cap of $22.27 billion and a "Moderate Buy" analyst consensus.